PADI4 and infection: As a result, PADI4 inhibition has been studied extensively as an approach to alleviate NET-associated pathologies that manifest in diabetes, sepsis, infection-induced lung injury, age-related cardiac fibrosis, deep-vein thrombosis and myocardial ischemia [137–142].